CYBERDYNE (7779) Fundamentals 2026 — P/E 308.3x, Revenue Analysis | SniperIQ
CYBERDYNE (7779) is a JP-listed Healthcare company in Medical - Devices with a market capitalization of ¥29.6B, trading at ¥222.00 on the JPX. This SniperIQ fundamentals page covers CYBERDYNE's valuation (P/E 308.3x, P/B 1.2x), profitability (net margin 4.0%), revenue (¥3.8B in FY2026), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is CYBERDYNE's market cap?
CYBERDYNE (7779) has a market capitalization of approximately ¥29.6B, trading at ¥222.00 on the JPX. Market cap moves with the live share price.
What is CYBERDYNE's P/E ratio?
CYBERDYNE's trailing twelve-month P/E ratio is 308.3x, with a price-to-book (P/B) of 1.2x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
How profitable is CYBERDYNE?
CYBERDYNE runs a net profit margin of 4.0%, a gross margin of 46.9%, and an operating margin of -28.7%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does CYBERDYNE generate?
CYBERDYNE reported revenue of ¥3.8B for fiscal year 2026, with net income of ¥153M and earnings per share (EPS) of 0.72. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does CYBERDYNE pay a dividend?
CYBERDYNE does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.
Is CYBERDYNE financially healthy?
CYBERDYNE carries a debt-to-equity ratio of 0.01x and a current ratio of 14.31x, with a market beta of 0.84. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is CYBERDYNE a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For CYBERDYNE (7779) the key facts are: market cap ¥29.6B, P/E 308.3x, revenue ¥3.8B, 52-week range 164-420. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.
Track CYBERDYNE's full fundamentals live
Get CYBERDYNE's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.